Chronus Health is a point-of-care diagnostics company developing a portable in-vitro diagnostics (IVD) platform to deliver real-time blood diagnostics at the point of care. The system is designed to provide lab results in minutes and to handle approximately 85% of the blood tests performed annually. Chronus leverages microfluidic and semiconductor technologies to create a compact, low-cost alternative to bulky, expensive central-lab analyzers. The company positions its platform to improve time-to-care and patient outcomes and to disrupt the clinical lab testing market. Chronus is a Fogarty Innovation company based in Mountain View, Calif. It intends to use new financing proceeds to scale research, engineering, and data-science teams and to accelerate product and technology development.

Total raised

$22M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2022